Novel Metabolites Associated with Decreased GFR in Finnish Men: A 12-Year Follow-Up of the METSIM Cohort
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251810044 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lilian Fernandes Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70211 Kuopio, Finland. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Metabolomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative Joint Undertaking, Academy of Finland, Centre of Excellence of Cardiovascular and Metabolic Diseases.
Abstract (Originalsprache)
Identification of the individuals having impaired kidney function is essential in preventing the complications of this disease. We measured 1009 metabolites at the baseline study in 10,159 Finnish men of the METSIM cohort and associated the metabolites with an estimated glomerular filtration rate (eGFR). A total of 7090 men participated in the 12-year follow-up study. Non-targeted metabolomics profiling was performed at Metabolon, Inc. (Morrisville, NC, USA) on EDTA plasma samples obtained after overnight fasting. We applied liquid chromatography mass spectrometry (LC-MS/MS) to identify the metabolites (the Metabolon DiscoveryHD4 platform). We performed association analyses between the eGFR and metabolites using linear regression adjusted for confounding factors. We found 108 metabolites significantly associated with a decrease in eGFR, and 28 of them were novel, including 12 amino acids, 8 xenobiotics, 5 lipids, 1 nucleotide, 1 peptide, and 1 partially characterized molecule. The most significant associations were with five amino acids, N-acetylmethionine, N-acetylvaline, gamma-carboxyglutamate, 3-methylglutaryl-carnitine, and pro-line. We identified 28 novel metabolites associated with decreased eGFR in the 12-year follow-up study of the METSIM cohort. These findings provide novel insights into the role of metabolites and metabolic pathways involved in the decline of kidney function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
- Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.
- Department of Medicine, Kuopio University Hospital, 70200 Kuopio, Finland.
ORCID-Profile: Lilian Fernandes Silva, Jagadish Vangipurapu, Anniina Oravilahti, Markku Laakso
Förderung
- Innovative Medicines Initiative Joint Undertaking
- Academy of Finland
- Centre of Excellence of Cardiovascular and Metabolic Diseases
- Sigrid Juselius Foundation grant
- Finnish Foundation for Cardiovascular Research
- Kuopio University Hospital
- European Union's 7th Framework (EMIF) resp. Horizon 2020 (BEAt-DKD) research and innovation programmes and EFPIA, with JDRF (BEAt-DKD).
- Sigrid Juselius Foundation
Zitieren
APA
Fernandes Silva, L., Vangipurapu, J., Oravilahti, A., & Laakso, M. (2024). Novel Metabolites Associated with Decreased GFR in Finnish Men: A 12-Year Follow-Up of the METSIM Cohort. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810044
Vancouver
Fernandes Silva L, Vangipurapu J, Oravilahti A, Laakso M. Novel Metabolites Associated with Decreased GFR in Finnish Men: A 12-Year Follow-Up of the METSIM Cohort. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810044
BibTeX
@article{FernandesSilva2024,
author = {Fernandes Silva, Lilian and Vangipurapu, Jagadish and Oravilahti, Anniina and Laakso, Markku},
title = {Novel Metabolites Associated with Decreased GFR in Finnish Men: A 12-Year Follow-Up of the METSIM Cohort},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251810044}
}
EUVIMED